EBIOX
EBIOX, officially known as Eberhard AG, is a prominent player in the biotechnology sector, headquartered in Switzerland (CH). Founded in 2000, the company has established itself as a leader in innovative biopharmaceutical solutions, focusing on the development of advanced therapies and diagnostics. With a strong operational presence across Europe and North America, EBIOX is dedicated to enhancing patient outcomes through cutting-edge research and development. The company’s core offerings include biologics and biosimilars, distinguished by their high efficacy and safety profiles. EBIOX's commitment to quality and innovation has earned it a notable position in the market, recognised for its contributions to the advancement of healthcare. With a track record of successful product launches and strategic partnerships, EBIOX continues to drive progress in the biotechnology industry, making significant strides towards improving global health.
DitchCarbon Score
How does EBIOX's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
EBIOX's score of 16 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
EBIOX's reported carbon emissions
EBIOX, headquartered in Switzerland (CH), currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. Furthermore, there are no documented reduction targets or climate pledges outlined in their initiatives. In the absence of concrete emissions data and commitments, it is essential to note that many companies in the industry are increasingly focusing on sustainability and carbon neutrality. EBIOX may be expected to align with these trends, potentially exploring future initiatives to address climate change and reduce their carbon footprint.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
EBIOX is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
